Insider Trading disclosures for Profound Medical Corp
The latest disclosure was made by Arun Menawat in Profound Medical Corp where a trade of 10,003
Common Shares done at an average price of $4.3
was reported to US exchanges on May 15, 2025.
Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Client Name |
Client Category |
Action |
Reported to Exchange |
Quantity |
Post Transaction Holding |
Traded % |
Avg. Price |
Value |
Security Type |
|
Arun Menawat
|
Director, CEO |
Purchase of securities on an exchange or from another person at price $ 4.33 per share. |
15 May 2025 |
10,003 |
575,062
|
-
|
4.3 |
43,263
|
Common Shares |
|
Arun Menawat
|
Director, CEO |
Purchase of securities on an exchange or from another person at price $ 4.73 per share. |
15 May 2025 |
12,027 |
587,089
|
-
|
4.7 |
56,888
|
Common Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges